FFTY:ARCA-Innovator IBD 50 Fund

ETF | Mid-Cap Growth | NYSE Arca

Last Closing Price

USD 33.35

Change

+0.34 (+1.03)%

Market Cap

USD 0.10B

Volume

0.20M

Yahoo Analyst Target

N/A

STA Analyst Target

N/A
Yahoo Analyst Rating

N/A

STA Analyst Rating

N/A

STA Verdict

Verdict

About

The investment seeks long-term capital appreciation. Under normal circumstances, the fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in companies included in the IBD? 50 Index. The fund will generally hold all of the companies included in the IBD? 50 Index other than during periods when the fund is rebalanced due to changes in the constitution of the IBD? 50 Index. The fund, however, will not invest in the IBD? 50 Index companies in the same proportion as reflected in the index.

Inception Date: 08/04/2015

Primary Benchmark: IBD 50 Index USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.13%

Management Expense Ratio: 0.80 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2018-02-23 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Mer Price(Change) Market Cap
IWP iShares Russell Midcap Growth 0.25 %

+1.68 (+1.36%)

USD 8.60B
IJK iShares S&P Mid-Cap 400 Growth 0.25 %

+2.50 (+1.15%)

USD 7.95B
VOT Vanguard Mid-Cap Growth 0.07 %

+1.75 (+1.35%)

USD 5.24B
MDYG SPDR S&P 400 Mid Cap Growth ET.. 0.15 %

+1.75 (+1.11%)

USD 1.06B
IVOG Vanguard S&P Mid-Cap 400 Growt.. 0.20 %

+1.58 (+1.18%)

USD 0.79B
RFG Guggenheim S&P Midcap 400 Pure.. 0.35 %

+1.47 (+0.93%)

USD 0.62B
JKH iShares Morningstar Mid-Cap Gr.. 0.30 %

+2.13 (+1.02%)

USD 0.26B
BFOR Barron's 400 0.65 %

+0.43 (+1.03%)

USD 0.21B
RYJ Guggenheim Raymond James SB-1 .. 0.75 %

+0.64 (+1.48%)

USD 0.19B
GDL GDL Fund The of Beneficial Int.. 0.00 %

+0.05 (+0.47%)

USD 0.18B

ETFs Containing FFTY

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Mid-Cap Growth)
Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.51% 13% F 62% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.51% 13% F 59% F
Trailing 12 Months  
Capital Gain 33.56% 93% A 89% B+
Dividend Return 0.23% 7% F 2% F
Total Return 33.79% 87% B+ 89% B+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 11.08% 100% A+ 77% C+
Dividend Return 11.09% 53% F 70% C-
Total Return 0.01% 7% F 1% F
Risk Return Profile  
Volatility (Standard Deviation) 18.17% 7% F 41% F
Risk Adjusted Return 61.02% 13% F 54% F
Market Capitalization 0.07B 14% F 21% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

FFTY:ARCA-Innovator IBD 50 Fund

ETF | Mid-Cap Growth | NYSE Arca

Last Closing Price

USD 33.35

Change

+0.34 (+1.03)%

Market Cap

USD 0.10B

Volume

0.20M

Yahoo Analyst Target

N/A

STA Analyst Target

N/A
Yahoo Analyst Rating

N/A

STA Analyst Rating

N/A

STA Verdict

Verdict

Values as of: 2018-02-23